
A New Pancreatic Cancer Drug Doubles Survival and Costs $39,800 a Month
Erin Calloway
Updated Sep 5, 2026
The FDA approved the first targeted therapy for advanced pancreatic cancer on August 27, more than six months ahead of its own deadline. In the trial it extended median survival from 6.7 months to 13.2 months. A one month supply costs about $39,800.
What the Drug Does
The drug is daraxonrasib, sold as Rasonque and made by Revolution Medicines of Redwood City, California. It is approved for advanced metastatic pancreatic cancer that has stopped responding to prior treatment.
It targets KRAS mutations, which are present in more than 90 percent of pancreatic cancer cases. The trial enrolled 500 patients. Reported side effects include skin rash, mouth sores, diarrhea and other digestive problems.
What the Numbers Mean and Do Not Mean
Median survival of 13.2 months against 6.7 months on chemotherapy is roughly six and a half additional months. That is a substantial result in a disease that has resisted almost everything.
It is not a cure, and the doctors involved have been direct about that. Dr. Andrew Coveler of the Fred Hutch Cancer Center said this medicine is not a cure but a significant improvement. FDA Acting Commissioner Kyle Diamantas said it is the agency’s fundamental duty to deliver more cures and meaningful treatments to patients as quickly as possible.
The Price and the Question It Raises
At roughly $39,800 for a one month supply, what a patient actually pays depends entirely on how the drug is covered.
That determination has not been published. Whether it falls under Part B or Part D changes the arithmetic substantially for a Medicare patient, and no reader should assume a particular out of pocket figure until their own plan confirms it.
Why This Reaches This Audience
Pancreatic cancer is diagnosed most often in people in their sixties and seventies. For a family that has already been through a first line of chemotherapy and been told there is nothing else, there is now something else.
The drug is on the market now and an oncologist can prescribe it today. The unresolved part is not whether the treatment exists. It is what it costs the household that needs it.
References: FDA approves landmark pancreatic cancer drug that’s shown to improve survival
AI-Assisted Content
The News And Beyond team was assisted by generative AI technology in creating this content.
Trending
Roger Waters Files for Contested Divorce at 83
Caption: Roger Waters performing in Ottawa, Canada, June 2012. Credit: Brennan Schnell / CC BY...
Susan Blake

Nvidia CEO Affair Raises Questions About Alleged China Spy
Caption: Nvidia CEO Jensen Huang speaks at Stanford University on April 30, 2026. Credit: Anders...
Erin Calloway

Meghan Steps Back From Brussels Speech as Harry Takes Stage
Caption: Meghan, Duchess of Sussex, at the South by Southwest conference in Austin, Texas, on...
Susan Blake

Baron Davis Fights Sister Over a House He Says He Owns
Caption: Former NBA player Baron Davis shooting a free throw, January 2010. Credit: MavsFan28 /...
Susan Blake

IRS Raises 2027 Standard Deduction as Tax Brackets Shift
Married couples filing jointly will get a $33,200 standard deduction for 2027, up $1,000, under...
Ryan Ellis

Senate Advances Energy Bill as Power-Cost Fight Intensifies
A 73-25 Senate vote has opened debate on an energy bill aimed at speeding construction...
Erin Calloway

Toys R Us Returns With More Than 160 Stores
Caption: Toys R Us store in Allen, Texas, November 2026. Credit: Zalkana / CC BY-SA...
Erin Calloway

More Holiday Shoppers Will Use AI to Hunt for Deals
More holiday shoppers plan to use AI to find gifts and compare prices, but most...
Alex Mercer

Golden Trump Statue on National Mall Targets His Draft Deferment
A gold-colored statue of Donald Trump rubbing his bare foot has appeared on the National...
Thomas Hale

Family Dollar Deal Includes $40 Million Refund Fund
Caption: Family Dollar store in Poplar, Montana. Credit: Thayne Tuason / CC BY-SA 4.0, via...
Laura Bennett








